Chimeric antigen receptor‐T cell therapies: The changing landscape

• Salyka M. Sengsayadeth,
• Bhagirathbhai R. Dholaria,
• Bipin N. Savani,
• Olalekan O. Oluwole

Affiliations

Salyka M. Sengsayadeth

Section of Hematology and Stem Cell Transplant Vanderbilt Ingram Cancer Center Department of Medicine Vanderbilt University Medical Center Nashville Tennessee USA

Bhagirathbhai R. Dholaria

Section of Hematology and Stem Cell Transplant Vanderbilt Ingram Cancer Center Department of Medicine Vanderbilt University Medical Center Nashville Tennessee USA

Bipin N. Savani

Section of Hematology and Stem Cell Transplant Vanderbilt Ingram Cancer Center Department of Medicine Vanderbilt University Medical Center Nashville Tennessee USA

Olalekan O. Oluwole

Section of Hematology and Stem Cell Transplant Vanderbilt Ingram Cancer Center Department of Medicine Vanderbilt University Medical Center Nashville Tennessee USA